School of Medicine


Showing 1-13 of 13 Results

  • Carl Feinstein

    Carl Feinstein

    Professor of Psychiatry and Behavioral Sciences at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly Interests Autism and Asperger's Disorder.

    Genetically-based neurodevelopmental disorder, including Velocardiofacial Syndrome, Smith-Magenis Syndrome, Williams Syndrome, and Fragile X Syndrome.

    Intellectual Disability (mental retardation) and psychiatric disorders.

    Developmental Language Disorder and Learning Disabilities.

    Sensory impairment in children, including visual and hearing impairment.

    Psychiatric aspects of medical illness and disability in children.

  • Lief Ericsson Fenno

    Lief Ericsson Fenno

    Instructor, Psychiatry and Behavioral Sciences

    Bio Dr. Fenno is a psychiatrist and Instructor at Stanford University School of Medicine.

    Leveraging his strengths in neuroscience research and bioengineering, his goal is to design, construct, validate, and apply novel molecular and viral tools to understand the brain in health and disease for the benefit of diverse patient populations. His clinical interests include the treatment of substance use disorders and co-occurring mood disorders.

    His specific research interests include the development and application of novel optogenetic tools that combine genetically encoded molecules and light to modulate neurons. Dr. Fenno directs a team focused on expanding the use of novel, intersectional viral targeting approaches, with the objective of precisely establishing links between neuron circuitry and behavior. He has patented advances for optically controlled CNS dysfunction and social dysfunction.

    Dr. Fenno has co-written articles on optogenetic tools and other topics in the journals Annual Review of Neuroscience, Neurobiology of Mental Illness, Molecular Psychiatry, Current Protocols in Neuroscience, Nature, and Cell. He is also the co-author of articles on neural mechanisms of autism spectrum disorder, which have appeared in Science Translational Medicine and Nature.

    Dr. Fenno has delivered presentations worldwide at events including the meeting of the National Science Foundation NeuroNex Program of Next Generation Networks for Neuroscience. He also has been an invited speaker at the Robarts Research Institute, a Canada-based facility accelerating medical discovery of treatments for some of the most debilitating diseases of our time, and the Gordon Research Conference on Molecular Pharmacology, an international forum for the presentation of pre-publication frontier research.

    For his scholarship and teaching achievements, Dr. Fenno has won numerous honors. They include the Laughlin Fellowship from the American College of Psychiatrists, which honors individuals deemed likely to make a significant contribution to the field of psychiatry, and the Humanism and Excellence in Teaching Award from the Arnold P. Gold Foundation, which honors exceptional teaching skills and commitment to the compassionate treatment of patients and families, students, and colleagues.

    Dr. Fenno is a member of the Society for Neuroscience, The American Medical Association, and the American Society of Addiction Medicine.

  • Caroline Fleck

    Caroline Fleck

    Adjunct Clinical Instructor, Psychiatry and Behavioral Sciences

    Bio Dr. Caroline Fleck received her doctorate in Psychology & Neuroscience from Duke University, and went on to specialize in cognitive behavioral therapies including Exposure and Response Prevention, Dialectical Behavior Therapy, Parent Management Training, Gottman Method Couples Therapy, and Behavioral Activation. She is the founder and clinical director of Luma - a network of evidence-based clinicians in private practice. Dr. Fleck is also a trainer, educator, and public speaker on the topics of evidence-based approaches in psychology, mindfulness, and the use of technology in mental health care. Her lectures and courses at Stanford focus on training residents, post-docs, and faculty in Dialectical Behavior Therapy, and risk management.

    More information can be found on her website: https://www.drcarolinefleck.com/

  • Judith Ford

    Judith Ford

    Professor (Research) of Psychiatry and Behavioral Sciences, Emeritus

    Current Research and Scholarly Interests We are using functional brain imaging methods (electrophysiology and magnetic resonance imaging) to study symptoms of schizophrenia such as auditory hallucinations, self-monitoring failures, emotional blunting, and cognitive deficits.

  • Katie Fracalanza

    Katie Fracalanza

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly Interests Dr. Fracalanza is interested in factors underlying the development and maintenance of mood and anxiety disorders. She has conducted research on cognitive factors thought to maintain anxiety, such as intolerance of uncertainty and perfectionism. She is interested in the patient perspective, and conducting research from a qualitative lens to better understand this.

  • Lawrence Fung MD PhD

    Lawrence Fung MD PhD

    Assistant Professor of Psychiatry and Behavioral Sciences (Child and Adolescent Psychiatry) at the Stanford University Medical Center

    Current Research and Scholarly Interests Dr. Lawrence Fung is a scientist and psychiatrist specialized in autism spectrum disorder (ASD), and the father of a neurodiverse teenager with ASD. He is the director of the Stanford Neurodiversity Project, which strives to uncover the strengths of neurodiverse individuals and utilize their talents to increase innovation and productivity of the society as a whole. He directs the Neurodiverse Student Support Program, Neurodiversity at Work Program (recently funded by Autism Speaks), and Adult Neurodevelopment Clinic at Stanford. Dr. Fung is an assistant professor in the Department of Psychiatry and Behavioral Sciences at Stanford University. His lab advances the understanding of neural bases of human socio-communicative and cognitive functions by using novel neuroimaging and technologies. His team devise and implement novel interventions to improve the lives of neurodiverse individuals by maximizing their potential and productivity. For example, he is conducting a study to demonstrate that specialized employment programs such as Neurodiversity at Work program will result in higher retention rates and quality of life.

Footer Links:

Stanford Medicine Resources: